Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3
Long Liao et al.
CANCER RESEARCH (2022)
Targeting PFKL with penfluridol inhibits glycolysis and suppresses esophageal cancer tumorigenesis in an AMPK/FOXO3a/BIM-dependent manner
Cancan Zheng et al.
ACTA PHARMACEUTICA SINICA B (2022)
MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma
Ronja-Melinda Komoll et al.
JOURNAL OF HEPATOLOGY (2021)
Disulfiram: a novel repurposed drug for cancer therapy
Chen Lu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
Identification of lysine isobutyrylation as a new histone modification mark
Zhesi Zhu et al.
NUCLEIC ACIDS RESEARCH (2021)
Autophagy, an accomplice or antagonist of drug resistance in HCC?
Yafei Wu et al.
CELL DEATH & DISEASE (2021)
Protein Lipidation by Palmitoylation and Myristoylation in Cancer
Chee Wai Fhu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Genome-wide identification of key regulatory lncRNAs in esophageal cancer metastasis
Wen Wen Xu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Anti-allergic drug azelastine suppresses colon tumorigenesis by directly targeting ARF1 to inhibit IQGAP1-ERK-Drp1-mediated mitochondrial fission
Hui-Fang Hu et al.
THERANOSTICS (2021)
Thalidomide leads to mandible hypoplasia through inhibiting angiogenesis and secondary hemorrhage in the fetal craniofacial region in rabbits
Yan Zhao et al.
TOXICOLOGY LETTERS (2020)
NMT1 and NMT2 are lysine myristoyltransferases regulating the ARF6 GTPase cycle
Tatsiana Kosciuk et al.
NATURE COMMUNICATIONS (2020)
Sorafenib Inhibits Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in Hepatocellular Carcinoma Cells
Pei-Ming Yang et al.
BIOMOLECULES (2020)
Desloratadine and loratadine stand out among common H1-antihistamines for association with improved breast cancer survival
Ildiko Fritz et al.
ACTA ONCOLOGICA (2020)
Myristoylation, an Ancient Protein Modification Mirroring Eukaryogenesis and Evolution
Thierry Meinnel et al.
TRENDS IN BIOCHEMICAL SCIENCES (2020)
Cellular rewiring in lethal prostate cancer: the architect of drug resistance
Marc Carceles-Cordon et al.
NATURE REVIEWS UROLOGY (2020)
Direct Targeting of CREB1 with Imperatorin Inhibits TGFβ2-ERK Signaling to Suppress Esophageal Cancer Metastasis
Wen Wen Xu et al.
ADVANCED SCIENCE (2020)
Echinatin suppresses esophageal cancer tumor growth and invasion through inducing AKT/mTOR-dependent autophagy and apoptosis
Pan Hong et al.
CELL DEATH & DISEASE (2020)
Advances in targeted therapy for esophageal cancer
Yan-Ming Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
Weiwei Tang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signalling pathway
Dongming Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6
Yuhong Luo et al.
GASTROENTEROLOGY (2019)
Adefovir dipivoxil sensitizes colon cancer cells to vemurafenib by disrupting the KCTD12-CDK1 interaction
Jie Yang et al.
CANCER LETTERS (2019)
Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance
Bin Li et al.
THERANOSTICS (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness
Wen Wen Xu et al.
CANCER LETTERS (2018)
A Map of Protein-Metabolite Interactions Reveals Principles of Chemical Communication
Ilaria Piazza et al.
CELL (2018)
Novel biomarkers in hepatocellular carcinoma
Felice De Stefano et al.
DIGESTIVE AND LIVER DISEASE (2018)
Desloratadine and depression, a drug safety signal based on worldwide spontaneous reporting of side effects
Jeltje Boer et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2018)
Investigation of Novel Regulation of N-myristoyltransferase by Mammalian Target of Rapamycin in Breast Cancer Cells
Marine Jacquier et al.
SCIENTIFIC REPORTS (2018)
NMT1 inhibition modulates breast cancer progression through stress-triggered JNK pathway
Lu Deng et al.
CELL DEATH & DISEASE (2018)
Drug repurposing from the perspective of pharmaceutical companies
Y. Cha et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
Lixia Gao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Blocking Myristoylation of Src Inhibits Its Kinase Activity and Suppresses Prostate Cancer Progression
Sungjin Kim et al.
CANCER RESEARCH (2017)
Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance
Bin Li et al.
CLINICAL CANCER RESEARCH (2016)
Drug combination therapy increases successful drug repositioning
Wei Sun et al.
DRUG DISCOVERY TODAY (2016)
Hippocalcin-Like 1 Suppresses Hepatocellular Carcinoma Progression by Promoting p21Waf/Cip1 Stabilization by Activating the ERK1/2-MAPK Pathway
Yonglong Zhang et al.
HEPATOLOGY (2016)
Inhibition of autophagy promotes apoptosis and enhances anticancer efficacy of adriamycin via augmented ROS generation in prostate cancer cells
Jizhong Wang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients
Xiao-Fei Zhang et al.
CANCER BIOLOGY & MEDICINE (2016)
Cell-free identification of novel N-myristoylated proteins from complementary DNA resources using bioorthogonal myristic acid analogues
Emi Takamitsu et al.
ANALYTICAL BIOCHEMISTRY (2014)
Mechanism of bFGF-binding Peptide Reversing Adriamycin Resistance in Human Gastric Cancer Cells
Xiangpeng Tan et al.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2014)
The growing landscape of lysine acetylation links metabolism and cell signalling
Chunaram Choudhary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Protein N-Myristoylation Plays a Critical Role in the Endoplasmic Reticulum Morphological Change Induced by Overexpression of Protein Lunapark, an Integral Membrane Protein of the Endoplasmic Reticulum
Koko Moriya et al.
PLOS ONE (2013)
Protein arginine methyltransferases and cancer
Yanzhong Yang et al.
NATURE REVIEWS CANCER (2013)
A fluorescence-based assay for N-myristoyltransferase activity
Victor Goncalves et al.
ANALYTICAL BIOCHEMISTRY (2012)
Proteomic Analysis of Fatty-acylated Proteins in Mammalian Cells with Chemical Reporters Reveals S-Acylation of Histone H3 Variants
John P. Wilson et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Myristoylation and Membrane Binding Regulate c-Src Stability and Kinase Activity
Parag Patwardhan et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Environment-mediated drug resistance: a major contributor to minimal residual disease
Mark B. Meads et al.
NATURE REVIEWS CANCER (2009)
Drug resistance and the solid tumor microenvironment
Olivier Tredan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Trafficking and signaling by fatty-acylated and prenylated proteins
Marilyn D. Resh
NATURE CHEMICAL BIOLOGY (2006)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Desloratadine: A new, nonsedating. oral antihistamine
RS Geha et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis
JP Zha et al.
SCIENCE (2000)
Share Paper
